当前位置: 首页 > 详情页

Lipid Use in Hospitalized Adults Requiring Parenteral Nutrition.

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]ViDia Kliniken Karlsruhe, Medizinische Klinik IV, Karlsruhe, Germany. [2]Department of General and Oncology Surgery with Intestinal Failure Unit, Stanley Dudrick's Memorial Hospital, Skawina, Poland. [3]Intensive Care Medicine Department, La Paz University Hospital, Madrid, Spain. [4]Department of Surgery, Division of Trauma and Acute Care Surgery, University of Florida College of Medicine, Gainesville, Florida, USA. [5]Department of General Surgery, Xuanwu Hospital Capital Medical University, Beijing, China. [6]Department of Surgery, Ohio State University Medical Center, Columbus, Ohio, USA. [7]Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy. [8]Department of Surgery, Oregon Health and Science University, Portland, Oregon, USA.
出处:
ISSN:

关键词: fish oil infections inflammation intensive care unit lipids meta-analyses omega-3 parenteral nutrition specialized pro-resolving mediator surgery

摘要:
In hospitalized patients, lipid emulsions are an integral part of balanced parenteral nutrition. Traditionally, a single lipid source, soybean oil, has been given to patients and was usually regarded as just a source of energy and to prevent essential fatty-acid deficiency. However, mixtures of different lipid emulsions have now become widely available, including mixtures of soybean oil, medium-chain triglycerides, olive oil, and fish oil. Fish oil is high in the ω-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). There is a growing body of evidence that these ω-3 fatty acids can exert beneficial immunomodulatory, anti-inflammatory, and inflammation-resolution effects across a wide range of patient groups including surgical, cancer, and critically ill patients. At least in part, these effects are realized via potent specialized pro-resolution mediators (SPMs). Moreover, parenteral nutrition including ω-3 fatty acids can result in additional clinical benefits over the use of standard lipid emulsions, such as reductions in infection rates and length of hospital and intensive care unit stay. Clinical and experimental evidence is reviewed regarding lipid emulsion use in a variety of hospitalized patient groups, including surgical, critically ill, sepsis, trauma, and acute pancreatitis patients. Practical aspects of lipid emulsion use in critically ill patients are also considered, such as how to determine and fulfill energy expenditure, how and when to consider parenteral nutrition, duration of infusion, and safety monitoring. © 2020 The Authors. Journal of Parenteral and Enteral Nutrition published by Wiley Periodicals, Inc. on behalf of American Society for Parenteral and Enteral Nutrition.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 2 区 营养学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 营养学
JCR分区:
出版当年[2018]版:
Q1 NUTRITION & DIETETICS
最新[2023]版:
Q2 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]ViDia Kliniken Karlsruhe, Medizinische Klinik IV, Karlsruhe, Germany.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院